+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

SEER and NAACCR data completeness methods: how do they impact data quality in Central Cancer Registries?



SEER and NAACCR data completeness methods: how do they impact data quality in Central Cancer Registries?



Journal of Registry Management 39(4): 185-186



There are 2 widely accepted methods for calculating data completeness in central cancer registries: The Surveillance, Epidemiology and End Results (SEER) Program's data completeness method and the North American Association of Central Cancer Registries' (NAACCR's) data completeness method. In recent years, the pros and cons of these methods have been discussed and debated by CTRs nationwide. The results from a myriad of studies have shown that each method offers its own set of strengths and unique applications. The aims of this paper are to provide an overview of both the SEER and NAACCR data completeness methods and to discuss the need for an alternative data completeness method.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055631525

Download citation: RISBibTeXText

PMID: 23493025


Related references

Evaluation of North American Association of Central Cancer Registries' (NAACCR) data for use in population-based cancer survival studies. Journal of the National Cancer Institute. Monographs 2014(49): 198-209, 2015

Comparative completeness and correspondence of cancer mortality data as collected by central statistics office and cancer registries. Tumori 68(6): 457-464, 1982

Feasibility study for collection of HER2 data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program central cancer registries. Cancer Epidemiology Biomarkers and Prevention 19(1): 144-147, 2010

The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries. Journal of the National Cancer Institute 101(7): 533-536, 2009

Merging Australia's national HIV and AIDS registries: improving quality and completeness of data. Australian and new Zealand Journal of Public Health 37(4): 393-394, 2013

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 112(1): 45-52, 2008

Comparative completeness and correspondence of cancer mortality data as collected by ISTAT and Cancer Registries. Tumori 68(6): 457-463, 1982

Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries. Bmc Cancer 4: 60, 2004

Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. European Journal of Cancer 45(5): 756-764, 2009

Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries. Journal of Registry Management 41(2): 77-84, 2014

Supplement: Use of the SEER-Medicare Data for Cancer-Related Health Services Research || Linking Physician Characteristics and Medicare Claims Data: Issues in Data Availability, Quality, and Measurement. Medical Care 40(8): Iv82-Iv95, 2002

Privacy of patient data in quality-of-care registries in cardiology and cardiothoracic surgery: the impact of the new general data protection regulation EU-law. European Heart Journal. Quality of Care and Clinical Outcomes 4(4): 239-245, 2018

Challenges in data quality: the influence of data quality assessments on data availability and completeness in a voluntary medical male circumcision programme in Zimbabwe. Bmj Open 7(1): E013562, 2017

Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer 109(8): 1607-1616, 2007

Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: a review of SEER data, 2004-2010. Cancer 120(Suppl. 23): 3815-3825, 2015